WORCESTER POLYTECHNIC INSTITUTE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1865-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.wpi.edu
Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 2
1 (33.3%)Development of Electroencephalography (EEG) and Magnetoencephalography (MEG) Source Reconstruction With Fast Multipole Method
Not Applicable
Recruiting
- Conditions
- Healthy
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Worcester Polytechnic Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06471244
- Locations
- 🇩🇪
Technical University Ilmenau, Ilmenau, Germany
🇩🇪Max-Planck-Institut für Kognitions- und Neurowissenschaften [Cognitive and Neuroscience], Leipzig, Germany
A Prospective Study of Human Bone Adaptation Using a Novel in Vivo Loading Model
Not Applicable
Completed
- Conditions
- Bone Loss
- First Posted Date
- 2019-10-22
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- Worcester Polytechnic Institute
- Target Recruit Count
- 102
- Registration Number
- NCT04135196
Dried Leaf Artemisia (DLA) Compared to Artemisinin Combination Therapy (ACT) vs Malaria
Phase 2
Withdrawn
- Conditions
- Malaria
- Interventions
- Drug: ACTDrug: DLA1Drug: DLA2
- First Posted Date
- 2017-06-27
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- Worcester Polytechnic Institute
- Registration Number
- NCT03199755
- Locations
- 🇨🇩
Rwanguba Reference Hospital, Goma, N Kivu, Congo, The Democratic Republic of the
News
No news found